Non-investigational SACT clinical trials

Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

This study looks at adding special radiotherapy (SABR) to standard treatment for some lung cancer patients. It aims to see if combining these treatments improves outcomes like how long patients live and how well their cancer is controlled.